Last Updated: 19/06/2024

Improving estimates of antimalarial drug resistance

Objectives

This project aims to generate the first data-driven, predictive maps of the changing landscape of artemisinin resistance in Asia.

Principal Investigators / Focal Persons

Jennifer Flegg

Rationale and Abstract

Antimalarial drugs are essential for the elimination of malaria. Resistance to all currently available antimalarials, including the pivotal artemisinin derivatives, has emerged and is spreading. These maps fill in the gaps where no information is available and can be used by health agencies to guide new polices about where and when the drug is appropriate to use.

Date

Jan 2023 — Dec 2026

Total Project Funding

$629,311

Project Site

Australia

SHARE
SHARE